-+ 0.00%
-+ 0.00%
-+ 0.00%

Recently, the State Drug Administration approved the marketing of bartolizumab injections declared by Jiaxi Holdings Co., Ltd. to be used in combination with conventional therapeutic drugs to treat adult systemic myasthenia gravis patients with positive anti-acetylcholine receptor antibodies.

Zhitongcaijing·10/22/2026 11:09:47
Listen to the news
Recently, the State Drug Administration approved the marketing of bartolizumab injections declared by Jiaxi Holdings Co., Ltd. to be used in combination with conventional therapeutic drugs to treat adult systemic myasthenia gravis patients with positive anti-acetylcholine receptor antibodies.